Join the 'Diabetes, Type 2' group to help and get support from people like you.

Diabetes, Type 2 Blog

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Obesity Fueling Rise in Diabetes Rates, Study Finds

Posted 2 Sep 2014 by

TUESDAY, Sept. 2, 2014 – The U.S. obesity epidemic is a driving force behind the rising rates of type 2 diabetes, according to a new study. Researchers looked at data from five national surveys spanning from 1976 through 2010 to determine how much the increase in diabetes over time could be explained by factors such as changing distribution of race, age and obesity in U.S. adults. The investigators found that the prevalence of diabetes in men rose from about 5 percent to more than 11 percent. In women, it rose from under 6 percent to nearly 9 percent. When the researchers looked at factors that might contribute to rising diabetes rates, obesity stood out. Although for men, it only explained about half the increase, according to the researchers. "Overweight and obesity explained most of the increase in the prevalence of diabetes in the U.S. during this time period," said study ... Read more

Related support groups: Obesity, Diabetes, Type 2

Health Tip: Manage Stress to Keep Diabetes in Check

Posted 25 Aug 2014 by

-- Physical and emotional stress can be problematic for diabetics, as it tends to cause blood sugar to rise. The American Diabetes Association suggests how to keep stress under control: Find ways to reduce stress, such as by taking an alternate route to avoid traffic, mending problems with a friend or changing to a less stressful job. Engage in regular physical activity. Do something fun, such as taking dance lessons, picking up a new hobby or practicing a craft. Volunteer in your community. Practice relaxation exercises. Read more

Related support groups: Anxiety and Stress, Diabetes, Type 2

Low Birth Weights May Put Black Women at Risk for Diabetes

Posted 22 Aug 2014 by

THURSDAY, Aug. 21, 2014 – Being born at a low birth weight puts black women at increased risk for type 2 diabetes, a new study suggests. The findings may partly explain high diabetes rates among black Americans, a population that has a high prevalence of low birth weight, the researchers added. Their study of more than 21,000 black women found that those with a low birth weight were 13 percent more likely to develop type 2 diabetes than those with a normal birth weight. The risk of diabetes was 40 percent higher in those with a very low birth weight. Low birth weight was defined as less than 5.5 pounds and very low birth weight as less than 3.3 pounds. A woman's body weight did not appear to affect the link between low birth weight and increased diabetes risk. Those who weren't obese still had a higher risk of diabetes if they had a low or very low birth weight. While the study found ... Read more

Related support groups: Diabetes, Type 2

Getting Healthier a Big Money-Saver for People With Diabetes

Posted 21 Aug 2014 by

THURSDAY, Aug. 21, 2014 – Not only is eating better and exercising healthy for people with diabetes, it can save them hundreds of health-care dollars a year, a new study finds. The study, led by Mark Espeland, a professor of public health sciences at Wake Forest Baptist Medical Center in Winston-Salem, N.C., included more than 5,100 overweight and obese type 2 diabetes patients. Participants ranged in age from 45 to 76, and were randomly assigned to either an intensive "lifestyle change program" focused on diet and exercise, or to a standard diabetes support and education program. The patients in the lifestyle group had higher levels of physical activity and maintained a lower body weight, resulting in better diabetes control, blood pressure, sleep, physical function and fewer symptoms of depression, the team reported. There were financial savings, too. Over 10 years of follow-up, the ... Read more

Related support groups: Diabetes, Type 2

Health Tip: Reducing Your Chances of Heart Disease if You Have Diabetes

Posted 18 Aug 2014 by

-- Diabetics are at increased risk of developing heart disease, but there are lifestyle changes you can make to help lower the risk. The National Heart Lung and Blood Association explains how you can reduce the risk of diabetic heart disease: Maintain healthy cholesterol. Keep high blood pressure in check (under 130/80 mm/Hg). Don't smoke Lose any excess weight. Eat a diet low in sodium, sugar and saturated and trans fats. Get plenty of regular exercise. Find ways to manage stress. Read more

Related support groups: Diabetes, Type 2, Heart Disease

40 Percent of Americans Will Develop Diabetes, CDC Projects

Posted 12 Aug 2014 by

TUESDAY, Aug. 12, 2014 – Approximately two out of every five Americans will develop type 2 diabetes at some point during their adult lives, according to new U.S. government estimates. The ongoing diabetes and obesity epidemics have combined with ever-increasing human lifespans to increase lifetime risk of type 2 diabetes to about 40 percent for both men and women, said lead study author Edward Gregg, chief of the epidemiology and statistics branch in the division of diabetes translation at the U.S. Centers for Disease Control and Prevention (CDC). "We weren't necessarily surprised that it increased, but we didn't expect it to increase this much," Gregg said. "Forty percent is a humbling number." The odds are even worse for certain minority groups. Half of black women and Hispanic men and women are predicted to develop type 2 diabetes during their lifetime, the researchers reported. ... Read more

Related support groups: Obesity, Diabetes, Type 2

FDA Approves Invokamet (canagliflozin/metformin) for Type 2 Diabetes

Posted 11 Aug 2014 by

RARITAN, N.J., August 8, 2014 – Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved Invokamet, a fixed dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes. Invokamet provides the clinical attributes of Invokana (canagliflozin), the first sodium glucose co-transporter 2 (SGLT2) inhibitor available in the United States, together with metformin, which is commonly prescribed early in the treatment of type 2 diabetes. Invokamet is the first fixed-dose combination of an SGLT2 inhibitor with metformin approved in the United States. "Invokamet combines, in one tablet, two complementary therapeutic approaches proven effective for managing type 2 diabetes,” said Richard Aguilar, M.D.*, Medical Director of Diabetes Nation. "Canagliflozin works with the kidney to pro ... Read more

Related support groups: Diabetes, Type 2, Metformin, Invokana, Canagliflozin

Coaching May Help Diabetics Battle Depression, Disease Better

Posted 6 Aug 2014 by

WEDNESDAY, Aug. 6, 2014 – Mental health coaching may help diabetes patients with depression and with lowering their blood sugar levels, a new study suggests. Many people with diabetes suffer depression, which can interfere with their ability to manage their diabetes through monitoring blood sugar levels, being active, eating healthy and taking their medications, the researchers noted. This study included diabetes patients in a rural, low-income area of central North Carolina. Nearly 16 percent of people in this area have diabetes, compared with 10 percent of people nationally. Thirty percent of these diabetes patients have depression and 65 percent are poor, the study authors wrote. Researchers referred 182 patients with newly diagnosed type 2 diabetes and depression to a diabetes educator and also to a mental health coach, who helped them find ways to deal with the stresses and ... Read more

Related support groups: Depression, Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

The 'Bear' Facts on Obesity and Diabetes

Posted 6 Aug 2014 by

TUESDAY, Aug. 5, 2014 – The ways grizzly bears deal with hibernation and fluctuating weight might offer valuable new clues to human obesity and diabetes, new research suggests. The study authors note that the tissues of obese people with type 2 diabetes become dangerously insensitive to insulin, the hormone that helps control the level of sugar in the blood. However, unlike people, insulin levels in grizzly bears do not change, the researchers found. Instead, the bears' cells seem to be able to control their ability to respond to insulin. In fact, in the fall – when grizzly bears are most obese – they are also the most sensitive to insulin, says a team led by Dr. Kevin Corbit, of the drug maker Amgen, Inc. According to Corbit's group, this happens because the activity of a key protein found in fat cells, called PTEN, is shut down. In fact, weeks into hibernation, grizzly bears ... Read more

Related support groups: Obesity, Diabetes, Type 2

Poor People With Diabetes Much More Likely to Lose a Limb: Study

Posted 4 Aug 2014 by

MONDAY, Aug. 4, 2014 – Poor people with diabetes are much more likely to lose a limb to the disease than affluent patients are, new research suggests. Researchers from the University of California, Los Angeles, found the odds of having a toe, foot or leg amputated was up to 10 times higher for diabetics who live in low-income neighborhoods. Most of these amputations are preventable if patients are diagnosed and get proper medical care sooner, the study authors noted. They added that their findings should prompt public officials to implement laws that help reduce barriers to health care. "When you have diabetes, where you live directly relates to whether you'll lose a limb to the disease. Millions of Californians have undergone preventable amputations due to poorly managed diabetes," lead author Dr. Carl Stevens, a clinical professor of medicine at the David Geffen School of Medicine at ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Jardiance Approved for Type 2 Diabetes

Posted 4 Aug 2014 by

FRIDAY, Aug. 1, 2014 – Jardiance (empagliflozin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes, which accounts for some 90 percent of diabetes cases in the United States, the agency said Friday in a news release. Affecting some 26 million people in the United States, the disease can lead to complications including heart disease, blindness and nerve and kidney damage, the FDA said. Jardiance, from a class of drugs called "sodium glucose co-transporter 2 inhibitors," is designed to block re-absorption of blood sugar by the kidneys. Its safety and effectiveness were evaluated in clinical studies involving 4,480 people with type 2 diabetes. The drug should not be used to treat type 1 diabetes, in people with severe kidney impairment, among people with increased ketones in the blood or urine, or in people on dialysis, the FDA said. The agency said it ... Read more

Related support groups: Diabetes, Type 2

FDA Approves Jardiance - New Type 2 Diabetes Drug

Posted 1 Aug 2014 by

FRIDAY, Aug. 1, 2014 – The U.S. Food and Drug Administration announced on Friday that it approved a new drug, Jardiance, to help fight type 2 diabetes. Jardiance (empagliflozin) "can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes," Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research, said in an agency statement. The FDA also recommended that Jardiance be used along with lifestyle changes, such as eating a healthy diet and exercising regularly. The combination of medication and lifestyle modification may improve blood sugar management for people with type 2 diabetes, they said. Over 26 million Americans are currently affected by type 2 diabetes, which accounts for about 90 percent of cases of diabetes, according to the agency. Jardiance, made by ... Read more

Related support groups: Diabetes, Type 2

FDA Approves Jardiance (empagliflozin) to Treat Type 2 Diabetes

Posted 1 Aug 2014 by

August 1, 2014 – The U.S. Food and Drug Administration today approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Type 2 diabetes affects approximately 26 million people and accounts for more than 90 percent of diabetes cases diagnosed in the United States. Over time, high blood sugar levels can increase the risk for serious complications, including heart disease, blindness, and nerve and kidney damage. "Jardiance provides an additional treatment option for the care of patients with type 2 diabetes," said Curtis J. Rosebraugh, M.D., M.P.H., director of the Office of Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research. “It can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes.” Jardiance is a sodium glucose co ... Read more

Related support groups: Diabetes, Type 2

Big Jump in Doctor's Office Visits for Young Adults With Diabetes

Posted 31 Jul 2014 by

THURSDAY, July 31, 2014 – A new report finds that by 2010, one in every 10 visits Americans made to their doctor's office involved diabetes, with the greatest rise among those aged 25 to 44. Data from the U.S. Centers for Disease Control and Prevention found the number of office visits for patients with diabetes in this age group jumped by 34 percent between 2005 and 2010. Almost 29 million Americans have diabetes, the CDC said, and managing the blood sugar disease costs almost $245 billion each year. Diabetes falls into two categories: Type 1, which is typically inherited and comprises about 5 percent of cases, and type 2, which is closely tied to obesity and makes up 95 percent of cases. Overall, the new report from the CDC's National Center for Health Statistics (NCHS) found that office-based visits for diabetes patients rose by 20 percent – from 94.4 million in 2005 to 113.3 ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Chronic Medical Conditions Can Shorten Seniors' Lives: Study

Posted 28 Jul 2014 by

MONDAY, July 28, 2014 – The more chronic medical conditions people have at retirement age, the shorter their life expectancy may be, a new study claims. Since nearly four in five older Americans have multiple health issues, scientists at Johns Hopkins Bloomberg School of Public Health in Baltimore said the findings may help explain why gains in life expectancy are slowing in the United States. "Living with multiple chronic diseases such as diabetes, kidney disease and heart failure is now the norm and not the exception in the United States," said lead author Eva DuGoff in a Hopkins news release. "The medical advances that have allowed sick people to live longer may not be able to keep up with the growing burden of chronic disease." "It is becoming very clear that preventing the development of additional chronic conditions in the elderly could be the only way to continue to improve life ... Read more

Related support groups: Diabetes, Type 2, Heart Failure, Congestive Heart Failure, Chronic Kidney Disease

Page 1 2 3 4 5 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Diabetic Ketoacidosis (in DM Type II), Diabetic Coma (in DM Type II), Diabetes Mellitus

Related Drug Support Groups

metformin, Victoza, Lantus, Januvia, Glucophage, glipizide, Novolog, Humalog, Welchol, view more... Byetta, Janumet, glyburide, Bydureon, Actos, Levemir, Lantus Solostar, glimepiride, Amaryl, bromocriptine, Novolin R, Onglyza, Invokana, pioglitazone, Avandia, chromium picolinate, Novolin N, Humulin N, Prandin, Glucophage XR, Humulin R, Tradjenta, GlipiZIDE XL, Glucotrol, NovoLog FlexPen, sitagliptin, Symlin, ActoPlus Met, acarbose, Humalog KwikPen, Glucotrol XL, Apidra, Humalog Pen, Glumetza, glyburide / metformin, exenatide, insulin glargine, liraglutide, gotu kola, Glucovance, Starlix, Novolin 70 / 30, Avandamet, repaglinide, NovoLog Mix 70 / 30, insulin regular, colesevelam, Janumet XR, Humalog Mix 75 / 25, lavender, Jentadueto, linagliptin, glipizide / metformin, Cycloset, rosiglitazone, Humulin N Pen, Novolin R PenFill, Symlin Pen, DiaBeta, insulin lispro, Jardiance, Riomet, Glynase, metformin / pioglitazone, Farxiga, miglitol, canagliflozin, Precose, Apidra Solostar, saxagliptin, nateglinide, Fortamet, Novolin N PenFill, Novolin N Innolet, Lantus OptiClik Cartridge, Novolin R Innolet, Humulin 70 / 30, Humalog Mix 50 / 50 Pen, NovoLog PenFill, Exubera, Insulin Pork Mix, glimepiride / pioglitazone, Humulin 70 / 30 Pen, Iletin NPH, insulin aspart, alogliptin, Micronase, Kombiglyze XR, chlorpropamide, Nesina, Oseni, insulin lispro / insulin lispro protamine, Tanzeum, tolazamide, Kazano, PrandiMet, alogliptin / pioglitazone, ReliOn / Novolin 70 / 30, ReliOn / Novolin N, Humulin U, SymlinPen 60, ReliOn / Novolin R, Trulicity, Afrezza, Humulin 50 / 50, Novolin 70 / 30 Innolet, Invokamet, Novolin 70 / 30 PenFill, Novolog Mix 70 / 30 PenFill, Juvisync, NovoLog Mix 70 / 30 FlexPen, Humalog Mix 50 / 50 KwikPen, Humalog Mix 75 / 25 Pen, Humalog Mix 50 / 50, SymlinPen 120, acetohexamide, Humalog Mix 75 / 25 KwikPen, NPH Insulin, Avandaryl, empagliflozin, canagliflozin / metformin, albiglutide, dapagliflozin, alogliptin / metformin, dulaglutide, dapagliflozin / metformin, Glycron, Metaglip, insulin glulisine, Diabinese, linagliptin / metformin, simvastatin / sitagliptin, insulin inhalation, rapid acting, metformin / rosiglitazone, insulin zinc extended, insulin zinc, insulin isophane / insulin regular, metformin / sitagliptin, pramlintide, metformin / saxagliptin, metformin / repaglinide, troglitazone, tolbutamide, Lente Iletin II, insulin detemir, Iletin Regular, Humulin R (Concentrated), Velosulin BR, Iletin II Regular Pork, Chromium GTF, Insulin Purified NPH Pork, Iletin II NPH Pork, Iletin Lente, Insulin Lente Pork, Novolin L, Humulin L, Cr-GTF, Rezulin, Tolinase, glimepiride / rosiglitazone, Glyset, insulin aspart / insulin aspart protamine, Duetact, insulin isophane, Tol-Tab, Orinase, Glynase PresTab, Dymelor, Iletin II Lente Pork